Relationship of p16 methylation status and serum α-fetoprotein concentration in hepatocellular carcinoma patients

Clinical Chemistry

Volumn 46, Issue 9, 2000, Pages 1420-1422

  Wong, I H N ^a   Lo, Y M D ^a   Lai, P B S ^a   Johnson, P J ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ARTICLE; CANCER GENETICS; CHRONIC HEPATITIS; DISEASE MARKER; DNA DETERMINATION; GENE MUTATION; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; METHYLATION; PROTEIN BLOOD LEVEL; SEQUENCE ANALYSIS;

EID: 0033811555     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.9.1420     Document Type: Article

References (12)

1. Microsatellite alterations in plasma DNA of small cell lung cancer patients
2. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer
3. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients
4. Epidemiological characteristics and risk factors of hepatocellular carcinoma
5. Hematogenous dissemination of hepatocytes and tumor cells following surgical resection of hepatocellular carcinoma: A quantitative analysis
6. Serum α-fetoprotein in the early stage of human hepatocellular carcinoma
7. Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: Observations in 31 patients
8. Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction
9. Methylation-specific PCR. A novel PCR assay for methylation status of CpG islands
10. Aberrant p15 promoter methylation in adult and childhood acute leukemias of nearly all the morphologic subtypes: Potential prognostic implications
11. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction
12. Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation